CEREBRAINT

Cerebra Integrated Technologies Share Price

₹9.48 -0.2 (-2.07%)

19 Nov, 2024 00:08

SIP TrendupStart SIP in CEREBRAINT

Start SIP

Performance

  • Low
  • ₹9
  • High
  • ₹9
  • 52 Week Low
  • ₹6
  • 52 Week High
  • ₹16
  • Open Price₹0
  • Previous Close₹10
  • Volume4,757

Investment Returns

  • Over 1 Month -18.13%
  • Over 3 Month -14.98%
  • Over 6 Month + 34.47%
  • Over 1 Year + 31.67%
SIP Lightning

Smart Investing Starts Here Start SIP with Cerebra Integrated Technologies for Steady Growth!

Invest Now

Cerebra Integrated Technologies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -2.1
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 115
  • P/B Ratio
  • 0.5
  • Average True Range
  • 0.36
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.44
  • RSI
  • 35.28
  • MFI
  • 68.69

Cerebra Integrated Technologies Financials

Cerebra Integrated Technologies Technicals

EMA & SMA

Current Price
₹9.48
-0.2 (-2.07%)
pointer
  • stock-down_img
  • Bullish Moving Average 1
  • stock-up_img
  • Bearish Moving Average 15
  • 20 Day
  • ₹10.26
  • 50 Day
  • ₹10.82
  • 100 Day
  • ₹10.50
  • 200 Day
  • ₹9.95

Resistance and Support

9.48 Pivot Speed
  • R3 9.48
  • R2 9.48
  • R1 9.48
  • S1 9.48
  • S2 9.48
  • S3 9.48

What's your outlook on Cerebra Integrated Technologies?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Cerebra Integ.Techs. has an operating revenue of Rs. 49.55 Cr. on a trailing 12-month basis. An annual revenue de-growth of -38% needs improvement, Pre-tax margin of -107% needs improvement, ROE of -22% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 5% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 11 which is a POOR score indicating inconsistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 134 indicates it belongs to a poor industry group of Computer-Hardware/Perip and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Cerebra Integrated Technologies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-13 Quarterly Results
2024-05-29 Quarterly Results
2024-02-14 Quarterly Results
2023-11-06 Quarterly Results

Cerebra Integrated Technologies F&O

Cerebra Integrated Technologies Shareholding Pattern

0.84%
0.03%
75.73%
23.4%

About Cerebra Integrated Technologies

  • NSE Symbol
  • CEREBRAINT
  • BSE Symbol
  • 532413
  • Managing Director
  • Mr. V Ranganathan
  • ISIN
  • INE345B01019

Similar Stocks to Cerebra Integrated Technologies

Cerebra Integrated Technologies FAQs

Cerebra Integrated Technologies share price is ₹9 As on 18 November, 2024 | 23:54

The Market Cap of Cerebra Integrated Technologies is ₹114.9 Cr As on 18 November, 2024 | 23:54

The P/E ratio of Cerebra Integrated Technologies is -2.1 As on 18 November, 2024 | 23:54

The PB ratio of Cerebra Integrated Technologies is 0.5 As on 18 November, 2024 | 23:54

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23